|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2011-2-2
|
|
pubmed:abstractText |
The adherence rate to National Cancer Institute (NCI) recommendations regarding inguinal lymph nodes dissection (ILND) in high grade T1 (G3T1) and T2-4 squamous cell carcinoma of the penis (SCCP) is not known. We assessed ILND rates in a North American cohort.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
1534-4681
|
|
pubmed:author |
pubmed-author:AbdollahFirasF,
pubmed-author:BudausLarsL,
pubmed-author:GuiterJacquesJ,
pubmed-author:IborraFrançoisF,
pubmed-author:JeldresClaudioC,
pubmed-author:JohalRupinderR,
pubmed-author:KarakiewiczPierre IPI,
pubmed-author:LatourMathieuM,
pubmed-author:LibermanDanielD,
pubmed-author:LughezzaniGiovanniG,
pubmed-author:MorganMonicaM,
pubmed-author:PatardJean-JacquesJJ,
pubmed-author:PerrottePaulP,
pubmed-author:ShariatShahrokh FSF,
pubmed-author:SunMaxineM,
pubmed-author:ThuretRodolpheR
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
439-46
|
|
pubmed:meshHeading |
pubmed-meshheading:20839061-Aged,
pubmed-meshheading:20839061-Carcinoma, Squamous Cell,
pubmed-meshheading:20839061-Follow-Up Studies,
pubmed-meshheading:20839061-Humans,
pubmed-meshheading:20839061-Lymph Node Excision,
pubmed-meshheading:20839061-Male,
pubmed-meshheading:20839061-Middle Aged,
pubmed-meshheading:20839061-Penile Neoplasms,
pubmed-meshheading:20839061-Population Surveillance,
pubmed-meshheading:20839061-Prognosis,
pubmed-meshheading:20839061-SEER Program,
pubmed-meshheading:20839061-Sentinel Lymph Node Biopsy,
pubmed-meshheading:20839061-Survival Rate,
pubmed-meshheading:20839061-United States,
pubmed-meshheading:20839061-Urologic Surgical Procedures, Male
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
A contemporary population-based assessment of the rate of lymph node dissection for penile carcinoma.
|
|
pubmed:affiliation |
Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Canada.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
